anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 228,331-228,360
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

228,331-228,360 of 303,780

filter-aware
11
The slide includes a disclaimer regarding forward-looking statements and a footnote defining the first row metric.Factset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
12
Factset | Results Presentation Deck | 22 slidesFactset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
13
Factset | Results Presentation Deck | 22 slidesFactset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
14
The chart illustrates the deduction of various operating expenses from revenue to arrive at adjusted operating income.Factset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
15
Includes adjustments for acquired revenues and currency impact.Factset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
17
The slide provides a standard financial reconciliation for EBITDA.Factset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
19
The table reconciles Net Cash Provided by Operating Activities to Free Cash Flow by subtracting Capital Expenditures.Factset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
21
The table reconciles Diluted Earnings per Common Share to Adjusted Diluted Earnings per Common Share by adding back Intangible Asset Amortization and adjusting for Discrete Tax Items.Factset | Results Presentation Deck | 22 slides · FactSet
Conference presentation Investor relations 1 hit
02
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations 1 hit
07
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Product1 hit
10
The matrix uses a qualitative 2x2 structure to illustrate market positioning.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Market Size1 hit
18
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
21
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Financials1 hit
22
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Financials1 hit
23
Includes GAAP/non-GAAP reconciliation footnote.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Financials1 hit
24
The slide uses a consistent bar chart format for four distinct business lines, providing both historical annual data and recent quarterly performance.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Financials1 hit
25
The slide uses a consistent color scheme where the most recent quarter (3Q23) is highlighted in a darker blue.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · Financials1 hit
28
The table shows non-GAAP financial adjustments including legal fees, penalties, and IPO-related compensation.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations 1 hit
29
Financial table showing adjustments for non-recurring items like legal fees, penalties, and IPO costs.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations 1 hit
30
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations 1 hit
02
Genelux | Investor Presentation Deck | 37 slidesGenelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
03
Genelux | Investor Presentation Deck | 37 slidesGenelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
06
Uses a process diagram to show the transition from cold to hot tumor states.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Solution1 hit
07
The central diagram illustrates the mechanism of action, contrasting 'Absence of Effector T Cells' (Platinum resistant) with 'Presence of Effector T Cells' (Platinum sensitive).Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Solution1 hit
08
Uses a pyramid diagram to represent the progression of clinical validation.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
09
The slide compares mPFS results against SOC-AURELIA and ELAHARE benchmarks.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Traction1 hit
11
The slide uses a table to compare clinical outcomes across patient subgroups (all, resistant, refractory) and a callout box for key takeaways.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
12
Waterfall plot and spider plot used to visualize clinical efficacy.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Traction1 hit
14
Includes a Kaplan-Meier plot with a table comparing historical data to VIRO-15 trial results.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a cross-trial comparison to highlight the efficacy of Olvi-Vec in heavily pre-treated patients.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Market Size1 hit